Restenosis in human vein bypass grafts

Atherosclerosis

Volumn 139, Issue 1, 1998, Pages 31-39

  Nikol, Sigrid ^a,b   Huehns, Tanya Y ^a   Weir, Lawrence ^b   Wight, Thomas N ^c   Höfling, Berthold ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b TUFTS UNIVERSITY   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Angioplasty; Atherectomy; Bypass surgery; Cell proliferation; Extracellular matrix

Indexed keywords

MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY SURGERY; EXTRACELLULAR MATRIX; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; PRIORITY JOURNAL; RESTENOSIS; SAPHENOUS VEIN GRAFT; TREATMENT OUTCOME;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; ARTERIAL OCCLUSIVE DISEASES; ATHERECTOMY; CELL DIVISION; EXTRACELLULAR MATRIX; GRAFT OCCLUSION, VASCULAR; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFLAMMATION; PROTEINS; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION; VEINS;

EID: 0032127089     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(98)00050-1     Document Type: Article

References (41)

1. Hamby R.I., Aintablian A., Handler M., Voleti C., Weisz D., Garvez J.W., Wisoff G. Aortocoronary saphenous vein bypass grafts: long-term patency, morphology and blood flow in patients with patent grafts early after surgery. Circulation. 60:1979;901-909.
2. Meeter K.L., van Domburg R., van den Brand M.J.B.M., Lubsen J., Bos E., Hugenholtz P.G. Incidence, risk and outcome of reintervention after aortocoronary bypass surgery. Br Heart J. 57:1987;427-435.
3. Foster E.D., Fisher L.D., Kaiser G.C., Myers W.O. Comparison of operative mortality and morbidity for initial and repeat coronary artery bypass grafting: the Coronary Artery Surgery Study (CASS) Registry Experience. Ann Thorac Surg. 38:1984;563-570.
4. Plokker H.W.T., Meester B.H., Serruys P.W. The Dutch experience in percutaneous transluminal angioplasty of narrowed saphenous veins used for aortocoronary arterial bypass. Am J Cardiol. 67:1991;361-366.
5. The M-Heart investigators, Hirshfeld J.W., Schwartz J.S., Jugo R., Macdonald R.G., Goldberg S., Savage M.P., Bass T.A., Vetrovec G., Cowley M., Taussig A.S., Whitworth H.B., Margolis J.R., Hill J.A., Pepine C.J. Restenosis after coronary angioplasty: a multivariate statistical model to relate lesion and procedure variables to restenosis. J Am Coll Cardiol. 18:1991;647-656.
6. Gruentzig A., Senning A., Siegenthaler W.E. Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty. New Engl J Med. 301:1979;61-68.
7. Nikol S., Höfling B. Regulation of smooth muscle cell proliferation and possible role in preventing restenosis post-angioplasty. Wien Klin Wochenschr. 13:1995;379-389.
8. Post M.J., Borst C., Kutz R.E. The relative importance of arterial remodeling compared with intimal hyperplasia in lumen renarrowing after balloon angioplasty: a study in the normal rabbit and the hypercholesterolemic yucatan micropig. Circulation. 89:1994;2816-2821.
9. Höfling B., Polnitz A.V., Backa D., von Arnim T., Lauterjung L., Jauch K.W., Simpson J.B. Percutaneous removal of atheromatous plaques in peripheral arteries. Lancet. i:1988;384-386.
10. Safian R.D., Gelbfish J.S., Erny R.E., Schmitt S.J., Schmidt D.A., Baim D.S. Coronary atherectomy: Clinical, angiographic, and histological findings and observations regarding potential mechanisms. Circulation. 82:1990;69-79.
11. Skalli O., Ropraz P., Treciak A., Benzonana G., Gillesen D., Gabbiani G. A monoclonal antibody against alpha-smooth muscle cell actin: a new probe for smooth muscle differentiation. J Cell Biol. 103:1986;2787-2796.
12. van Muijen G.N.P., Ruiter D.J., Warnaar S.O. Coexpression of intermediate filament polypeptides in human fetal and adult tissues. Lab Invest. 57:1987;359-369.
13. Parums D.V., Cordell J.L., Micklem K., Heryet A.R., Gatter K.C., Mason D.Y. JC70: a new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections. J Clin Pathol. 43:1990;752-757.
14. Bartek J., Bartova J., Lukas J., Staskova Z., Vojtesek B., Lane D.P. Immunohistochemical analysis of the p53 oncoprotein on paraffin sections using a series of novel monoclonal antibodies. J Pathol. 169:1993;27-34.
15. Pulford K.A.F., Rigney E.M., Micklem K.J., Jones M., Stross W.P., Gatter K.C., Mason D.Y. KP1: a new monoclonal antibody that detects a monocyte/macrophage associated antigen in routinely processed tissue sections. J Clin Pathol. 42:1989;414-421.
16. Rose D.S.C., Maddocks P.H., Brown D.C. Which proliferation markers for routine histology? A comparison of five antibodies. J Clin Pathol. 47:1994;1010-1014.
17. Wadlo G., Broeker E.B., Bassewitz D.B., Feige U., Sorg C. A monoclonal antibody to a differentiation antigen present on human macrophages and absent from monocytes. J Immunol. 134:1985;1487-1492.
18. Franke WW, Winter S, Schmid E, Söllner P, Nagle RB, Hämmerling G, Achtstätter T, Moll R. Monoclonal cytokeratin antibody recognizing a heterotypic complex: immunological probing of conformational states of cytoskeletal proteins in filaments and in solution. J Cell Biol (in press).
19. Lark M.W., Yeo T.K., Henderson M.A.R., Lara S., Hellström I., Hellström K.E., Wight T.N. Arterial chondroitin sulfate proteoglycan: localization with a monoclonal antibody. J Histochem Cytochem. 36:1988;1211-1221.
20. Abraham J.A., Whang J.L., Tumolo A., Mergia A., Friedman J., Gospodarowicz D., Fiddes J. Human basic fibroblast growth factor: nucleotide sequence and genomic organization. EMBO J. 5:1986;2523-2528.
21. Ardinger H.H., Ardinger R.H., Bell G.I., Murray J.C. RFLP for the human transforming growth factor beta-1 gene (TGFB) on chromosome 19. Nucleic Acids Res. 16:1988;8202.
22. Saez C.G., Myers J.C., Shows J.B., Leinwand L.A. Human nonmuscle myosin heavy chain mRNA: Generation of diversity through alternative polyadenylation. Proc Natl Acad Sci USA. 87:1990;1164-1168.
23. Nikol S., Isner J.M., Pickering J.G., Kearney M., Leclerc G., Weir L. Expression of transforming growth factor-β1 is increased in human vascular restenosis lesions. J Clin Invest. 90:1992;1582-1592.
24. Hoefler H., Childers H., Montminy M.R., Lechan R.M., Goodman R.H., Wolfe H.J. In situ hybridization methods for the detection of somatostatin mRNA in tissue sections using antisense RNA probes. Histochem J. 18:1986;597-604.
25. de Feyter P.J., van Suylen R.J., de Jaegere P.P.T., Topol E.J., Serruys P.W. Balloon angioplasty for the treatment of lesions in saphenous vein bypass grafts. J Am Coll Cardiol. 21:1993;1539-1549.
26. Savage M.P., Douglas J.S. Jr., Fischman D.L., Pepine C.J., King S.B. 3rd, Werner J.A., Bailey S.R., Overlie P.A., Fenton S.H., Brinker J.A., Leon M.B., Goldberg S. Stent placement compared with balloon angioplasty for obstructed coronary vein bypass grafts. Saphenous Vein De Novo Trial Investigators. New Engl J Med. 337:1997;740-747.
27. Isner J.M., Kearney M., Bauters C., Leclerc G., Nikol S., Pickering J.G., Riessen R., Weir L. Use of human tissue specimens obtained by directional atherectomy to study restenosis. Trends Cardiovasc Med. 4:1994;213-221.
28. Isner JM, Kearney M, Pickering JG, Leclerc G, Nikol S, Weir L. The pathology of restenosis. In: Vetrovec, Carabello, editors. Invasive Cardiology: Current Diadnostic and Therapeutic Issues, Ch. 17. Mount Kisko, NY: Futura, 1996:277-299.
29. Speir E., Modali R., Huang E.S., Leon M.B., Shawl F., Finkel T., Epstein S.E. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science. 265:1994;391-394.
30. Alloisio N., Venezia N.D., Rana A., Andrabi K., Texier P., Gilsanz F., Cartron J.P., Delauney J., Chishti A.H. Evidence that red blood cell protein p55 may participate in the skeleton-membrane linkage that involves protein 4.1 and glycophorin C. Blood. 82:1993;1323-1337.
31. Wight T.N. Cell biology of arterial proteoglycans. Arteriosclerosis. 9:1989;1-20.
32. Nikol S., Weir L., Sullivan A., Sharaf B., White C.J., Zemel G., Hartzler G., Stack R., Leclerc G., Isner J.M. Persistently increased expression of the transforming growth factor-β gene in human vascular restenosis. Analysis of 62 patients with one or more episodes of restenosis. Cardiovasc Pathol. 3:1994;57-64.
33. Gonschior P., Nerlich A., Mack B., Wiest I.R.M., Höfling B. Immunohistochemical cell characterisation from primary and restenosis tissue. VASA J Vasc Dis. 23:1994;15-22.
34. Riessen R., Isner J.M., Blessing E., Loushin C., Nikol S., Wight T.N. Regional differences in the distribution of the proteoglycans biglycan and decorin in the extracellular matrix of atherosclerotic and restenotic human coronary arteries. Am J Pathol. 144:1994;962-974.
35. Bulkley B.H., Hutchins G.M. Accelerated 'atherosclerosis'. A morphologic study of 97 saphenous vein coronary artery bypass grafts. Circulation. 55:1977;163-168.
36. Garrett K.N., Edwards W.D., Kaufmann U.P., Vlietstra R.E., Holmes D.R. Differential histopathology of primary atherosclerotic and restenotic lesions in coronary arteries and saphenous vein bypass grafts: analysis of tissue obtained from 73 patients by directional atherectomy. J Am Coll Cardiol. 17:1991;442-448.
37. Gabbiani G., Kocher O., Bloom W.S., Vandekerckhove J., Weber K. Actin expression in smooth muscle cells of rat aortic intimal thickening, human atheromatous plaque, and cultured rat aortic media. J Clin Invest. 73:1984;148-152.
38. Nikol S., Murakami N., Pickering G., Kearney M., Leclerc G., Höfling B., Isner J.M., Weir L. Differential expression of nonmuscle myosin II isoforms in human atherosclerotic plaque. Atherosclerosis. 130:1997;71-85.
39. O'Brien E.R., Alpres C.E., Stewart D.K., Feruson M., Tran N., Gordon D., Benditt E.P., Hinohara T., Simpson J.B., Schwartz S.M. Proliferation in primary and restenotic coronary atherectomy tissues: implications for antiproliferative therapy. Circ Res. 73:1993;223-231.
40. Bennett M.R., Evan G.I., Schwartz S.M. Apoptosis of rat vascular smooth muscle cells is regulated by p53-dependent and -independent pathways. Circ Res. 77:1995;266-273.
41. Nikol S., Huehns T.Y., Höfling B. Molecular biology and post-angioplasty restenosis. Atherosclerosis. 123:1996;17-31.